Latest Views & News

Accrol, Forterra & more inflation impact

By Steve Moore | Tuesday 18 May 2021

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

A trading update today from tissue group Accrol (ACRL) includes “input costs already announced by the industry are increasing significantly in the near term”, whilst similar from masonry products company Forterra (FORT) includes that it “has recently started to see significant cost inflation across a wide range of categories with the strength of the recovery to date leading to some supply chain shortages”. Shares in the former are currently, at 54p, approaching 13% lower, whilst in the latter, at 288.5p, more than 1.5% higher. Hmmm…

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was